While it has yet to be determined whether the activation of chaperones like ERp29 is the underlying mechanism of 4-PBA induced reduction of LACV in BCECs, this strategy represents a promising approach to combatting LACV-induced encephalitis. The gene discussed is ERP29; the disease is viral encephalitis.